ResMed Inc.

US$235.30As of Sun 8 Nov 2026, 12:00 UTC
NYSE:RMDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 15.93%
Div yield 1.12%
ROE 26.40%
Medical Instruments & Supplies
Beta (5Y) 0.76
PE TTM 21.43
TSR TTM (3.68%)
Mkt cap US$33.10B
ROIC 26.88%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$283
20.48%
247.98%
Hold 4|12|9|1|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
2.98
2.97
2.96
3.06
6.61%
10.73%
4.95%
9.25%
Revenue$B
2.030
2.010
2.022
2.016
11.81%
6.62%
7.50%
4.13%
Peers (US$33.10B)
Cap (US$)
PE
52.14B
60.81x
27.85B
44.91x
36.34B
57.81x
Capital
TTM
5Y
10Y
Leveragex
1.049
0.543
0.401
EBIT/Intx
0.791
0.197
0.196
Own earn%
(55.27)
(293.39)
(256.23)
Sh yield%
39.57
7.87
7.45
Owners
Insiders/Inst%
6.25
74.58
Short interest%
2.90
SBC / revenue%
3.29
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
8–15
$1 testx
0.0
Incr. ROIC%
1